Evidence map›Paper›PMID 39088432›Full record

ArticlePloS one2024

Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles.

Naoki Suzuki, Makoto Kanzaki, Masashi Koide, Rumiko Izumi, Ryo Fujita, Tadahisa Takahashi, Kazumi Ogawa, Yutaka Yabe, Masahiro Tsuchiya, Masako Suzuki and 15 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Naoki SuzukiDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0001-8880-8554
Makoto KanzakiGraduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.
Masashi KoideDepartment of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Rumiko IzumiDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ryo FujitaDepartment of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tadahisa TakahashiDepartment of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Kazumi OgawaDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yutaka YabeDepartment of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Masahiro TsuchiyaDepartment of Nursing, Tohoku Fukushi University, Sendai, Japan.ORCID 0000-0002-7000-4547
Masako SuzukiDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ryuhei HaradaDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akiyuki OhnoDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroya OnoDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Naoko NakamuraDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kensuke IkedaDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hitoshi WaritaDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shion OsanaDivision of Biomedical Engineering for Health and Welfare, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.
Yoshitsugu OikawaDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takafumi ToyoharaDivision of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takaaki AbeDivision of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Muliang RuiDepartment of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0009-0000-3614-8080
Satoru EbiharaDepartment of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0002-3574-649X
Ryoichi NagatomiDivision of Biomedical Engineering for Health and Welfare, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.
Yoshihiro HagiwaraDepartment of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Masashi AokiDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic inclusion body myositis (sIBM) is a muscle disease in older people and is characterized by inflammatory cell invasion into intact muscle fibers and rimmed vacuoles. The pathomechanism of sIBM is not fully elucidated yet, and controversy exists as to whether sIBM is a primary autoimmune disease or a degenerative muscle disease with secondary inflammation. Previously, we established a method of collecting CD56-positive myoblasts from human skeletal muscle biopsy samples. We hypothesized that the myoblasts derived from these patients are useful to see the cell-autonomous pathomechanism of sIBM. With these resources, myoblasts were differentiated into myotubes, and the expression profiles of cell-autonomous pathology of sIBM were analyzed. Myoblasts from three sIBM cases and six controls were differentiated into myotubes. In the RNA-sequencing analysis of these "myotube" samples, 104 differentially expressed genes (DEGs) were found to be significantly upregulated by more than twofold in sIBM, and 13 DEGs were downregulated by less than twofold. For muscle biopsy samples, a comparative analysis was conducted to determine the extent to which "biopsy" and "myotube" samples differed. Fifty-three DEGs were extracted of which 32 (60%) had opposite directions of expression change (e.g., increased in biopsy vs decreased in myotube). Apolipoprotein E (apoE) and transmembrane protein 8C (TMEM8C or MYMK) were commonly upregulated in muscle biopsies and myotubes from sIBM. ApoE and myogenin protein levels were upregulated in sIBM. Given that enrichment analysis also captured changes in muscle contraction and development, the triggering of muscle atrophy signaling and abnormal muscle differentiation via MYMK or myogenin may be involved in the pathogenesis of sIBM. The presence of DEGs in sIBM suggests that the myotubes formed from sIBM-derived myoblasts revealed the existence of muscle cell-autonomous degeneration in sIBM. The catalog of DEGs will be an important resource for future studies on the pathogenesis of sIBM focusing on primary muscle degeneration.

Indexed as

Muscle Fibers, SkeletalMyositis, Inclusion BodyAgedBiopsyCell DifferentiationCells, CulturedFemaleGene Expression ProfilingHumansMaleMiddle AgedMyoblastsTranscriptome

Identifiers

PMID39088432
PMCPMC11293708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.